John W. Smither - Insider Trading & Ownership

Entity
Individual
Location
C/O Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas, California
Summary
The estimated net worth of John W. Smither is at least $589 K dollars as of June 7, 2024. John W. Smither is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $541 K. John W. Smither is the Director of GENELUX Corp and owns shares of GENELUX Corp (GNLX) stock worth about $48.2 K.
All Insider Reports
All Insider Reports

Ownership of John W. Smither

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $541 K Feb 13, 2024
GNLX GENELUX Corp Director $48.2 K -$18.7 K -27.9% May 29, 2024
AMTI Applied Molecular Transport Inc. Director Dec 27, 2023
EFTR, EFTRW eFFECTOR Therapeutics, Inc. Director Jun 22, 2023
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director Jan 1, 2024

Insider Transactions Reported by John W. Smither:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership